Surgalign has been granted a patent for a surgical method using soft tissue implants obtained from xenograft sources. The method involves a chemical process to sterilize, remove antigens, and strengthen the implants, resulting in superior structural integrity. The patent also covers processes for treating and producing such implants. GlobalData’s report on Surgalign gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData


Premium Insights Surgalign Holdings Inc - Company Profile

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Surgalign, Prosthetic cardiac valves was a key innovation area identified from patents. Surgalign's grant share as of January 2024 was 58%. Grant share is based on the ratio of number of grants to total number of patents.

Patent granted for surgical method using xenograft implants

Source: United States Patent and Trademark Office (USPTO). Credit: Surgalign Holdings Inc

A recently granted patent (Publication Number: US11883437B2) outlines a surgical method for utilizing a graft in the treatment of human patients, particularly in hernia surgery or abdominal repair. The method involves the preparation of the graft using bovine dermis with a native dermal matrix. The process includes treating the dermis with specific solutions such as aqueous alkaline sodium sulfide, saline, and hydrogen peroxide, followed by dehydration with organic solvents like acetone or ethanol. Importantly, the graft maintains the histoarchitecture of the native dermal matrix and is non-crosslinked, ensuring its effectiveness in surgical procedures.

Furthermore, the patent details specific steps and parameters for the preparation of the graft, such as the duration of treatment with solutions, volume ratios, concentrations of salts and hydrogen peroxide, and dehydration processes. The method allows for customization of the graft shape through punching, stamping, or cutting the bovine dermis into various predetermined shapes, including squares, rectangles, circles, triangles, ovals, or even irregular and asymmetric shapes. By following the outlined steps and parameters, surgeons can effectively utilize the prepared graft in hernia surgeries, providing a potentially improved treatment option for patients requiring such procedures.

To know more about GlobalData’s detailed insights on Surgalign, buy the report here.

Premium Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.